Plenary Item 5. Implementation of the international drug control treaties

(a) Changes in the scope of control of substances

Chair: We resume considerations of Item 5, especially item 5.a. CND is called to perform its treaty mandated function related to scheduling.

CND Secretariat: Pre-session documentation is available online. Including scheduling recommendations by the WHO-ECDD.

Chair: First, we’ll consider scheduling recommendations on substances under 1961, then 1971, then 1988. First, 1961, communicated after the 44th meeting of the WHO ECDD. Thanks to Justice Tetey for supporting the Commission with information about these substances. Brorphineon Schedule 1 of the 1961

Gilles Forte, WHO: Synthetic opioid related to ezitramine, controlled under Schedule 1 of 1961 convention. Brorphine is an opioid receptor agonist producing analgesia, greater potency than morphine but less than fentanyl. Based on mechanism of action, likely to be abused and potential for dependence similar to other opioids. Potential to produce other typical opioid effects – respiratory depression and sedation. Number of deaths associated with use in combination with other opioids or with benzodiazepines. Detected seizures from countries in several regions. No therapeutic use. As it has potential for similar abuse and dependence and similar ill effects of eschoedule opioids under 1961 scheduling, the ECDD recommended its scheduling under Schedule 1 of 1961 Convention.

Chair: Simple majority needed.

Voting in favour: Algeria, Angola, Australia Austria,  Bahrain,, Belgium, Bolivia, Brazil, Canada, China, Colombia, Côte d’Ivoire, Ecuador, Egypt, El Salvador, France, Germany, Ghana, Hungary, Iran, Italy, Jamaica, Japan, Kazakhstan, Kenya, Libya, Lithuania, Mexico, Morocco, Nepal, Netherlands, Nigeria, Pakistan, Peru, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, Ukraine, United Kingdom, United States, Uruguay

Voting not in support: None.

Abstaining: None

Chair: Total of 49 votes in favour. 0 against. 0 abstentions. CND decides to include morphine on Schedule 1 of 1961 convention.

Chair: Metonitazene recommended for Schedule 1961 Convention.

Gilles Forte, WHO: Metonitazene is a synthetic opioid related to etonizane and clonitazene currently controlled under Schedule 1. It’s an opioid receptor agonist producing analgesia, respiratory depression… More potent than fentanyl and hydromorphone. Likely to produce dependence similar to other opioids. Potential to produce deaths through respiratory depression. Use associated with deaths. In many cases, used in combination with other opioids or benzodiazepines. Detected in seizures in countries in several regions. No therapeutic use. As it has potential for similar abuse and dependence and similar ill effects of eschoedule opioids under 1961 scheduling, the ECDD recommended its scheduling under Schedule 1 of 1961 Convention.

Chair: Simple majority needed in accordance with rules.

Voting in favour of recommendation? Algeria, Angola, Australia Austria,  Bahrain,, Belgium, Bolivia, Brazil, Canada, China, Colombia, Côte d’Ivoire, Ecuador, Egypt, El Salvador, France, Germany, Ghana, Hungary, Iran, Italy, Jamaica, Japan, Kazakhstan, Kenya, Libya, Lithuania, Mexico, Morocco, Nepal, Netherlands, Nigeria, Pakistan, Peru, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, Ukraine, United Kingdom, United States, Uruguay

Voting not in support: None.

Abstaining? None

Chair: Total of 49 votes in favour. 0 against. 0 abstaining. The CND includes metonitazene in Schedule 1 of 1961 Conventions.

Chair: Recommendation on adding eutylone to Schedule 2 of the 1961 Convention.

Gilles Forte, WHO: Eutylone is a synthetic cathinone similar to other cathinones such as methylone and ethylpentylone that are currently controlled under Schedule 2 of the 1971 convention. Effects such as euphoria, tachycardia, anxiety, psychosis, delirium and other cathinones and stimulants such as methamphetamine. Likely to be abused and produce dependence like methamphetamine. Deaths have been reposted and adverse events include hypertension and seizures. Eutylone has been detected in sezired materials in several regions. No therapeutic use. As potential for severe abuse as other cathinones in Schedule 2 on 1971 Convention, WHO ECDD suggest scheduling under this schedule.

Chair: We invite the Commission to vote on this recommendation. As per the 1971 convention, we need a ⅔ majority.

Voting in favour: Algeria, Angola, Australia Austria,  Bahrain,, Belgium, Bolivia, Brazil, Canada, China, Colombia, Côte d’Ivoire, Ecuador, Egypt, El Salvador, France, Germany, Ghana, Hungary, Iran, Italy, Jamaica, Japan, Kazakhstan, Kenya, Libya, Lithuania, Mexico, Morocco, Nepal, Netherlands, Nigeria, Pakistan, Peru, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, Ukraine, United Kingdom, United States, Uruguay

Voting not in support: None.

Abstaining: None

Chair: 49 votes in favour. 0 against. 0 abstentions. 36 votes are required for the ⅔ majority. The CND decided to include eutylone on Schedule 2 of the 1971 convention.

Now turning to recommendations under the 1988 Convention. Recommendations by the INCB to add three fentanyl precursors under Table 1 of the 1988 Convention. 

INCB: INCB has the responsibility to assess chemicals used in manufacturing drugs illicitly to determine whether they should be controlled. The Board submitted to the CND Chair three fentanyl precursors on Table 1 of the 1988 Conventions. The substances are precursors, chemicals used to produce fentanyl and analogues. These substances are scheduled under the 1961 Convention. 10-100x stronger than heroin. Overdose deaths in users and inadvertent exposure of law enforcement and personnel along distribution change. Voting will be separate but I will refer to their short names on the slides: First, 4AP, which produces NPP, already in the Convention. 1-boc-4-AP, derivative of 4AP which is used to produce denfatly and analogues. Norfentanyl is an immediate precursor. The Board finds that 4AP, 1-boc-4-AP and norfentanyl are suitable for the illicit manufacture of fentanyl. Evidence exists from foresici analytics mostly illicit fentanl, use theis substances. There is no known legitimate trade expect for reference and research purposes. 63 countries provided comments on this. They did not foresee any difficulties placing these on the tables of the 1988 conventions. We recommend adding all three to Table 1 of 1988 conventions. International control of all substances will limit their availability and reduce the quantity of fentanyl available. No adverse effect on availability of substances for legititmiate purposes.

Chair: On recommendation of INCB to include 4AP in Table 1 of 1988 convention, I invite the CND to take a vote. A ⅔ majority is required.

Voting in favour: Algeria, Angola, Australia Austria, Bahrain, Belgium, Brazil, Canada, China, Colombia, Côte d’Ivoire, Ecuador, Egypt, France, Germany, Ghana, Hungary, Iran, Italy, Jamaica, Japan, Kazakhstan, Kenya, Libya, Lithuania, Mexico, Morocco, Nepal, Netherlands, Nigeria, Pakistan, Peru, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Ukraine, United Kingdom of Great Britain, United States of America, Uruguay

Voting not in support? None.

Abstaining? None

Chair: 48 votes in favour. 0 against. 0 abstentions. 36 votes are required for the ⅔ majority. The CND decided to include 4AP on Table 1 of the 1988 convention.

On recommendation of INCB to include 1-boc-4-AP in Table 1 of 1988 convention, I invite the CND to take a vote. A ⅔ majority is required.

Voting in favour: Algeria, Angola, Australia Austria,  Bahrain,, Belgium, Bolivia, Brazil, Canada, China, Colombia, Côte d’Ivoire, Ecuador, Egypt, El Salvador, France, Germany, Ghana, Hungary, Iran, Italy, Jamaica, Japan, Kazakhstan, Kenya, Libya, Lithuania, Mexico, Morocco, Nepal, Netherlands, Nigeria, Pakistan, Peru, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, Ukraine, United Kingdom, United States, Uruguay

Voting not in support? None.

Abstaining? None

Chair: 49 votes in favour. 0 against. 0 abstentions. 36 votes are required for the ⅔ majority. The CND decided to include 1-boc-4-AP on Table 1 of the 1988 convention.

On recommendation of INCB to include norfentanyl in Table 1 of 1988 convention, I invite the CND to take a vote. A ⅔ majority is required.

Voting in favour: Algeria, Angola, Australia, Austria, Bahrain, Belgium, Brazil, China, Colombia, Côte d’Ivoire, Ecuador, Egypt, El Salvador, France, Germany, Ghana, Hungary, Iran (Islamic Republic of), Italy, Jamaica, Japan, Kazakhstan, Kenya, Libya, Lithuania, Mexico, Morocco, Nepal, Netherlands, Nigeria, Pakistan, Peru, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, Ukraine, United Kingdom of Great Britain, United States of America, Uruguay

Voting not in support? None.

Abstaining? None

Chair: 47 votes in favour. 0 against. 0 abstentions. 36 votes are required for the ⅔ majority. The CND decided to include norfentanyl on Table 1 of the 1988 convention.

Kenya: We appreciate the research into the dire issues that impact human health. We have been working with WHO against the negative effects of drug abuse. We support the recommendations. We have not recorded any medical use of [substance]. We wish to consider Tramadol and Ketamine whose misuse are on the rise, so their control is critical particularly in the developing countries. We have reviewed our narcotic control act and decided to control these two substances and hope we can discuss them at this international forum as well.

USA: These chemicals are used in the production in fentanyl that is killing people across the world, this decision will matter for years to come, it saves lives. We thank INCB and UNODC for supporting the efforts to review these chemicals and put them under international control. I thank my colleagues who provided data and all, for demonstrating our commitment to work together.

El Salvador: Regarding the vote on 4AP – when we raised our name, it was not read out.

Chair: I apologize, we will correct the records now. This means we have 49 votes in favor.

Senegal: Strict control of these substances will contribute to the preserving the health of our people, particularly young people, who are most vulnerable to new psychoactive substances. We think it is important to strengthen detective measures just as well. It would be useful to update detection equipment among less developed countries to ensure they wont become weak links in this global struggle. Harmonized interconnected tools as well as proactive information exchange is essential in fulfilling our commitments to the conventions. Stronger coordination between states will safeguard us against criminal groups.

Chair: Thank you everyone. We have now closed item 5 on our agenda.

Leave a Reply

Your email address will not be published.